Bioscientia Institute of Medical Diagnostics
Bioscientia is a German medical laboratory diagnostics provider operating 25+ regional labs under the Sonic Healthcare Germany group, serving physician practices, hospitals, and consumers with clinical chemistry, genetics, allergy, hygiene, microbiome, and direct-to-consumer at-home testing.
- Company typePrivate
- Founded1970
- HeadquartersIngelheim Am Rhein, Germany
- Headcount1,001–5,000
- GTM typeB2B and B2C
- OfferingServices
What Bioscientia Institute of Medical Diagnostics does
Bioscientia Institute of Medical Diagnostics, legally Bioscientia Healthcare GmbH, is a German medical laboratory diagnostics provider headquartered in Ingelheim and operating a network of 25+ regional laboratories across Germany. Founded more than 50 years ago and now part of the Sonic Healthcare Germany group, the company serves physician practices (general practitioners and specialists), hospitals and clinic chains, dental practices, gynecologists, and — via its Labortest-Zuhause e-commerce platform — health-conscious consumers. The diagnostic menu spans clinical chemistry, hematology, serology, microbiology, genetics, molecular diagnostics, allergy diagnostics, hospital hygiene, and DNA-based microbiome analysis, with operational sub-units covering Genetik (genetic diagnostics and counseling), ZHI Hygiene, Biocontrol (industrial/environmental testing), Krankenhaus Labormanagement (hospital lab outsourcing), and Mikrobiom-Analyse. Underlying technologies include Next Generation Sequencing (16S-rRNA) for microbiome work, Component-Resolved Diagnostics (CRD) and FlowCAST for allergy, and standard molecular methods (NIPT, array-CGH, sequencing) for genetics.
The business operates two parallel revenue mechanics. The core B2B model sells diagnostic services to healthcare providers under Germany's statutory (EBM/GKV) and private (GOÄ/PKV) reimbursement schedules, supported by the Honoraria billing advisory service that helps practices optimize Wirtschaftlichkeitsbonus (efficiency bonus) claims. A digital workflow layer — the star.net electronic order entry system and the doc.net physician result portal/app with Elpho curves and pathological-value highlighting — is embedded into physician practice workflows, generating switching costs. The consumer channel sells at-home dried-blood-spot and stool test kits via labortest-zuhause.de, with results delivered through the PatApp and optional post-test nutrition/medical consultation via the Clickdoc video platform. Cross-cutting services include the Probentransport sample logistics network, CME-accredited Fortbildungen continuing education for physicians, and Präventivmedizin preventive health check-ups at the Ingelheim site.
The company is privately held under Sonic Healthcare Germany GmbH & Co. KG, led by CEO Dr. Oliver Harzer (MBA) and COO Frank Exner, and is supervised by multiple regional Kassenärztliche Vereinigungen across at least 11 German states. It holds no publicly disclosed revenue figures and has not raised venture or private equity capital.
Bioscientia Institute of Medical Diagnostics firmographics
Firmographics- Name
- Bioscientia Institute of Medical Diagnostics
- Legal name
- Bioscientia Healthcare GmbH
- Website
- https://bioscientia.de
- Company type
- Private
- Founded year
- 1970
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Bioscientia is a German medical laboratory diagnostics provider operating 25+ regional labs under the Sonic Healthcare Germany group, serving physician practices, hospitals, and consumers with clinical chemistry, genetics, allergy, hygiene, microbiome, and direct-to-consumer at-home testing.
- Ownership category
- akta.pro rank
Bioscientia Institute of Medical Diagnostics industry classification
Industry- Product category
- Medical Laboratory Diagnostics
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Testing Laboratories and Services (541380)
- SIC
- Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
- akta.pro secondary industries
- Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH), Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD), Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE)
Keywords
Where Bioscientia Institute of Medical Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Ingelheim Am Rhein
- HQ country
- Germany
- HQ region
- Europe
Offices15 records
Markets served
Bioscientia Institute of Medical Diagnostics business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- B2B Laboratory Diagnostic Services: Laboratory diagnostic testing services billed to physician practices, hospitals, and healthcare providers. Services are billed through statutory health insurance (GKV/Gesetzliche Krankenversicherung) and private insurance (PKV/Private Krankenversicherung) reimbursement systems. The company supports practices with EBM (Einheitlicher Bewertungsmaßstab) and GOÄ (Gebührenordnung für Ärzte) billing, including Wirtschaftlichkeitsbonus optimization services.
- Direct-to-Consumer At-Home Testing Kits: Sale of at-home test kits (Vitamin D, minerals, microbiome, vaginom) directly to consumers via labortest-zuhause.de online shop. Kits are mailed to consumers who collect samples at home and return them for laboratory analysis.
- Continuing Medical Education (CME) / Fortbildungen: Fee-based medical training and continuing education programs for healthcare professionals.
- Billing Advisory Services (Honoraria): Information and advisory services on EBM and GOÄ billing topics, including Wirtschaftlichkeitsbonus optimization. Some materials and training are fee-based.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Vitamin D Home Test Kit |
| One time/ perpetual license | Pay-as-you-go | Mineral Analysis Home Test Kit |
| One time/ perpetual license | Pay-as-you-go | Gut Microbiome Analysis Kit |
| Other | Pay-as-you-go | Nutrition and Medical Consultation |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Bioscientia Institute of Medical Diagnostics product offering
Product offeringCore offering
Bioscientia operates a Germany-wide network of 25+ accredited medical diagnostic laboratories providing routine and specialized testing (clinical chemistry, hematology, serology, microbiology, genetics, molecular diagnostics, allergy diagnostics, microbiome analysis) to physician practices, hospitals, and clinics. It also sells direct-to-consumer at-home test kits (vitamin D, minerals, gut microbiome, vaginal microbiome) through its Labortest-Zuhause e-commerce platform, and offers physician-facing digital tools (doc.net app, star.net order entry) and billing advisory services.
Product overview
Bioscientia Institute of Medical Diagnostics operates as a multi-location medical diagnostics laboratory network in Germany, offering a comprehensive portfolio of diagnostic services organized under distinct business units: Core Labordiagnostik (blood, microbiology, serology, specialized testing), Genetik (genetic diagnostics including NIPT, panels, sequencing), Hygiene (ZHI hospital infection control), Biocontrol (industrial testing), Krankenhaus Labormanagement (hospital lab services), and Mikrobiom-Analyse (DNA-based microbiome testing). The company provides physician-facing platforms including star.net Labor (online ordering) and doc.net (result portal with mobile apps), direct-to-consumer services through Labortest-Zuhause (home test kits), and supplementary services such as Honoraria (billing support) and Präventivmedizin (preventive health check-ups). The diagnostic portfolio includes specific tests for iron deficiency, celiac disease, lactose intolerance, insulin resistance, allergies, vitamin B12 deficiency, and Hashimoto's thyroiditis, alongside a continuously updated Analysenverzeichnis catalog of all available tests across their 25+ laboratory locations.
Differentiator
Problem solved
Functional benefit
Brands
- Bioscientia doc.net: Digital physician portal and app for accessing laboratory results
- PatApp
- Mein Direktlabor
- Labortest-Zuhause
- Honoraria
- Präventivmedizin
Products and services
- Labordiagnostik (Medical Diagnostics) Core laboratory diagnostic services encompassing blood analysis, liver function, microbiology, serology, and specialized testing across multiple body systems (cardiovascular, neurological, metabolic, hormonal). Includes specific diagnostic profiles for iron deficiency, celiac disease, lactose intolerance, insulin resistance (HOMA-Index), allergies (component-resolved diagnostics, FlowCAST), vitamin B12 deficiency (Holo-TC, MMA), Hashimoto's thyroiditis, and calprotectin stool testing. Targeted at physician practices, hospitals, and clinics.
- Genetik (Genetic Diagnostics) Genetic diagnostics services across multiple specialty indications (eyes, blood, fertility, brain, heart, metabolism, oncology) including cytogenetics, FISH, array-CGH, NIPT, and sequencing methods, paired with genetic counseling. Targeted at physicians and patients requiring hereditary disease and reproductive risk assessment.
- Hygiene (ZHI - Zentrum für Hygiene und Infektionsschutz) Hospital hygiene consulting and laboratory services including hygiene audits, infection control testing, and continuing education through the ZHI-Akademie. Targeted at hospitals, clinics, and healthcare facilities requiring infection prevention support.
- Biocontrol Laboratory testing services for industrial and environmental applications, including diagnostic offerings and service packages for quality control. Targeted at industrial clients requiring environmental monitoring and quality assurance testing.
- Krankenhaus Labormanagement (KHLM) Hospital laboratory management services providing complete laboratory concepts, laborkonzepte, and operational service offerings for medical facilities. Targeted at hospitals and clinic networks requiring outsourced or co-managed laboratory operations.
- Mikrobiom-Analyse (Microbiome Analysis) DNA-based microbiome analysis services for gut and vaginal health, using Next Generation Sequencing technology for comprehensive flora composition reporting. Targeted at physicians and consumers seeking preventive and diagnostic microbiome insights.
- Labortest-Zuhause (Home Test Kits) Direct-to-consumer home testing kits including Vitamin D testing, Mineralstoff testing, Darmmikrobiom (gut microbiome) analysis, and Vaginom analysis using dried blood spot and stool sample collection methods. Results delivered digitally with optional nutrition and medical consultation via Clickdoc video platform. Targeted at health-conscious individual consumers.
- Mein Direktlabor Direct laboratory service enabling patients to order tests independently and visit partner locations for sample collection without physician referral. Targeted at individual consumers seeking preventive health testing without a doctor's prescription.
- Präventivmedizin (Preventive Medicine) Preventive medicine services including comprehensive health check-ups at the Ingelheim location, body composition analysis via bioelectrical impedance analysis, and laboratory testing. Targeted at health-conscious individuals seeking preventive screening.
- Honoraria (Billing Advisory) Billing information and advisory service providing updates on GOÄ and EBM regulations, economic efficiency bonuses (Wirtschaftlichkeitsbonus), exception codes, and practical guidance for medical practice billing optimization. Some materials and training are fee-based. Targeted at physician practices seeking billing compliance and revenue optimization.
- Pränataldiagnostik (Prenatal Diagnostics) Prenatal genetic diagnostic services including first trimester screening, non-invasive prenatal testing (NIPT), chromosomal analyses, FISH, array-CGH, and molecular genetic analyses. Targeted at expectant parents and obstetricians seeking genetic risk assessment.
- Probentransport (Sample Logistics) Sample logistics and transportation services for medical practices to send specimens to Bioscientia laboratories. Targeted at physician practices and clinics requiring reliable specimen transport.
- Fortbildungen (CME Training) Fee-based medical training and continuing education programs (CME-accredited Fortbildungen) for healthcare professionals. Targeted at physicians, lab staff, and healthcare practitioners seeking ongoing professional education.
Quantifiable outcome
- Successfully passed microbiome ring trial (Ringversuch) with 100% accuracy
- +1 more outcomes
Companies that use Bioscientia Institute of Medical Diagnostics
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Bioscientia Institute of Medical Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
Feature5 records
Bioscientia Institute of Medical Diagnostics partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor and core.
- IntermedminorIntermed (shop.intermed.de) is a cooperation partner providing sample collection and shipping materials (Entnahme- und Versandmaterial, EVM). Bioscientia directs its customers to Intermed's online shop for ordering collection supplies. This is an operational supply partnership supporting the core diagnostic service delivery.
- Sonic Healthcare Germany GmbH & Co. KG (Parent Company)coreBioscientia is part of Sonic Healthcare Germany GmbH & Co. KG, a large international medical diagnostics group. The parent company provides corporate backing, global best practices, and operational scale. Labortest-Zuhause is branded/engineered under Sonic Healthcare Germany.
- intersoft consulting services AGminorExternal data protection officer (Datenschutzbeauftragter) for Bioscientia Healthcare GmbH, providing GDPR and data protection compliance advisory services.
Scale indicators1 record
Recent moves6 records
Expansion highlights6 records
Bioscientia Institute of Medical Diagnostics competitors and assessment
Company assessmentDirect peers
- Cerascreen: German direct-to-consumer at-home testing company selling nutritional, hormone, microbiome, and allergy test kits via online channels — directly competitive with Bioscientia's Labortest-Zuhause DTC portfolio.
- Synlab: Europe's largest medical diagnostics provider, operating an extensive German laboratory network serving physicians, hospitals, and clinics with a comparable full-menu diagnostic portfolio including genetics, microbiology, and specialty testing.
- Labor Berlin: Hospital-affiliated German medical diagnostics provider offering a broad routine and specialty test menu; comparable as a clinical laboratory operator serving both outpatient physicians and inpatient facilities.
- amedes Holding: European provider of medical-diagnostic services in laboratory diagnostics, gynecology, and human genetics operating a multi-site German network that competes directly with Bioscientia's specialty test offerings.
- LADR (Laborärztliche Arbeitsgemeinschaft für Diagnostik und Rationalisierung): German network of regional medical laboratories offering clinical chemistry, microbiology, immunology, and human genetics to physician practices — direct competitor with multi-state regional coverage analogous to Bioscientia's structure.
- MVZ Labor Dessau: Mid-sized German medical laboratory group providing routine and specialty diagnostic services to regional physician networks — comparable in scale and operating model to Bioscientia's regional lab footprint.
- Medivere Diagnostics: German provider of self-sampling diagnostics and laboratory services with at-home test kits spanning allergies, hormones, microbiome, and vitamins — comparable DTC competitor to Labortest-Zuhause.
Broad incumbents
- Sonic Healthcare: Parent company group of Bioscientia and a global pathology and diagnostics operator; overlapping service portfolio (clinical lab, genetics, microbiology) at much larger scale across multiple countries.
- Eurofins Genomics: International life-sciences services group with strong presence in genomic and molecular diagnostic testing services — overlaps with Bioscientia's genetic and molecular diagnostics offerings at broader scale.
Regional players
- Helios Klinikum Laboratories / Fresenius (Helios): German hospital group with in-house laboratory operations and procurement influence; represents both a potential Krankenhaus Labormanagement customer and a competitive threat via captive lab capacity.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Bioscientia Institute of Medical Diagnostics social profiles
Digital presenceBioscientia Institute of Medical Diagnostics compliance and trust
Trust signalCompliance3 records
Bioscientia Institute of Medical Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioscientia Institute of Medical Diagnostics leadership team
Management profileNumber of profiles
Profiles1 record
Bioscientia Institute of Medical Diagnostics subsidiaries and ownership
Company hierarchySubsidiaries5 records
Bioscientia Institute of Medical Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioscientia Institute of Medical Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioscientia Institute of Medical Diagnostics
What does Bioscientia Institute of Medical Diagnostics do?
Bioscientia operates a Germany-wide network of 25+ accredited medical diagnostic laboratories providing routine and specialized testing (clinical chemistry, hematology, serology, microbiology, genetics, molecular diagnostics, allergy diagnostics, microbiome analysis) to physician practices, hospitals, and clinics. It also sells direct-to-consumer at-home test kits (vitamin D, minerals, gut microbiome, vaginal microbiome) through its Labortest-Zuhause e-commerce platform, and offers physician-facing digital tools (doc.net app, star.net order entry) and billing advisory services.
Is Bioscientia Institute of Medical Diagnostics a public or private company?
Bioscientia Institute of Medical Diagnostics is a private company. It is classified as corporate owned and is currently operating.
When was Bioscientia Institute of Medical Diagnostics founded?
Bioscientia Institute of Medical Diagnostics was founded in 1970. It employs 1,001 to 5,000 people.
Where is Bioscientia Institute of Medical Diagnostics based?
Bioscientia Institute of Medical Diagnostics is headquartered in Ingelheim Am Rhein, Germany, in the Europe region.
How does Bioscientia Institute of Medical Diagnostics make money?
Four revenue lines are on record. B2B Laboratory Diagnostic Services are the primary driver. The others are direct-to-Consumer At-Home Testing Kits, continuing Medical Education (CME) / Fortbildungen and billing Advisory Services (Honoraria).
Who are Bioscientia Institute of Medical Diagnostics's main competitors?
Direct peers on record are Cerascreen, Synlab, Labor Berlin, amedes Holding, LADR (Laborärztliche Arbeitsgemeinschaft für Diagnostik und Rationalisierung), MVZ Labor Dessau and Medivere Diagnostics. Broad incumbents are Sonic Healthcare and Eurofins Genomics. Helios Klinikum Laboratories / Fresenius (Helios) is listed as a regional player.
Does Bioscientia Institute of Medical Diagnostics have an API?
No public API is recorded for Bioscientia Institute of Medical Diagnostics.
What industry is Bioscientia Institute of Medical Diagnostics in?
Bioscientia Institute of Medical Diagnostics's product category is Medical Laboratory Diagnostics. Its primary akta.pro industry code is HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays), with a secondary code of HLAAAFAH, Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal). Its NAICS code is 621511 and its SIC code is 8071.